Ngo-2021 i-FDA eVunyiweyo yeChiza eNtsha 1Q-3Q

Utshintsho luqhubela phambili inkqubela.Xa kuziwa kubutsha kuphuhliso lwamachiza amatsha kunye neemveliso zonyango lwebhayoloji, Iziko le-FDA loVavanyo lweZiyobisi kunye noPhando (CDER) lixhasa ishishini loxubo mayeza kuwo onke amanqanaba enkqubo.Ngokuqonda kwayo isayensi esetyenziselwa ukudala iimveliso ezintsha, ukuvavanya kunye neenkqubo zokuvelisa, kunye nezifo kunye neemeko ezilungiselelwe ukunyanga iimveliso ezintsha, i-CDER ibonelela ngeengcebiso zenzululwazi kunye nokulawula ezifunekayo ukuzisa unyango olutsha kwiimarike.
Ubukho bamachiza amatsha kunye neemveliso zebhayoloji zihlala zithetha iindlela ezintsha zonyango lwezigulane kunye nenkqubela phambili yokhathalelo lwempilo kuluntu lwaseMelika.Ngesi sizathu, i-CDER ixhasa ukusungula izinto ezintsha kwaye idlala indima ephambili ekuncedeni ukuqhubela phambili uphuhliso lwamachiza amatsha.
Nyaka ngamnye, i-CDER ivuma uluhlu olubanzi lwamachiza amatsha kunye neemveliso zebhayoloji:
1. Ezinye zezi mveliso ziimveliso ezintsha ezingazange zisetyenziswe kwiklinikhi.Apha ngezantsi kukho uluhlu lwamaqumrhu amatsha emolekyuli kunye neemveliso ezintsha zonyango zebhayoloji ezivunywe yi-CDER ngo-2021. Olu luhlu aluqukethe izitofu, iimveliso ze-allergenic, igazi kunye neemveliso zegazi, i-plasma derivatives, i-cellular kunye ne-gene therapy iimveliso, okanye ezinye iimveliso ezivunyiweyo ngo-2021 ngu. Iziko loVavanyo lweBiologics kunye noPhando.
2. Ezinye ziyafana, okanye zihlobene, neemveliso ezivunyiweyo ngaphambili, kwaye ziya kukhuphisana nezo mveliso kwindawo yentengiso.Jonga Drugs@FDA ngolwazi malunga nawo onke amachiza avunyiweyo e-CDER kunye neemveliso zebhayoloji.
Amachiza athile ahlelwa njengamaqumrhu amatsha emolekyuli ("NMEs") ngeenjongo zokuphononongwa kwe-FDA.Uninzi lwezi mveliso ziqulethe iimoieties ezisebenzayo ezingavunywanga yi-FDA ngaphambili, nokuba sisithako esinye sechiza okanye njengenxalenye yemveliso edibeneyo;ezi mveliso zihlala zibonelela ngonyango olutsha olubalulekileyo kwizigulana.Amanye amachiza abonakaliswe njenge-NMEs ngeenjongo zolawulo, kodwa nangona kunjalo aqulathe i-moieties esebenzayo esondeleleneyo ne-moieties esebenzayo kwiimveliso ezivunywe ngaphambili yi-FDA.Umzekelo, i-CDER ihlela iimveliso zebhayoloji ezifakwe kwisicelo phantsi kwecandelo lama-351 (a) loMthetho weNkonzo yezeMpilo kaRhulumente njengee-NME ngeenjongo zokuphononongwa kwe-FDA, nokuba i-Arhente ivume ngaphambili i-moiety esebenzayo enxulumeneyo kwimveliso eyahlukileyo.Ukuhlelwa kwechiza kwe-FDA njenge "NME" ngeenjongo zokuphonononga kwahlukile kwisigqibo se-FDA sokuba ingaba imveliso yechiza "liqumrhu elitsha lekhemikhali" okanye "NCE" ngaphakathi kwentsingiselo yoMthetho woKutya, iChiza, kunye neCosmetic.

Hayi. Igama leziyobisi Isithako esisebenzayo Umhla wokuvunywa Usetyenziso oluvunywe yi-FDA ngomhla wokuvunywa*
37 Exkivity mobocertinib 9/15/2021 Ukunyanga umhlaza wemiphunga we-epidermal ophucukileyo wasekhaya okanye we-metastatic ongengowomncinci kunye ne-epidermal growth factor receptor exon 20 efakelwayo utshintsho
36 Skytrofa lonapegsomatropin-tcgd 8/25/2021 Ukunyanga ubude obufutshane ngenxa yokungakhuseli ngokwaneleyo kwehomoni yokukhula engapheliyo
35 Korsuva iflikefalin 8/23/2021 Ukunyanga i-pruritus ephakathi ukuya kweyobunzima ehambelana nesifo sezintso ezingapheliyo kubantu abathile
34 Welireg ibelzutifan 8/13/2021 Ukunyanga isifo se-von Hippel-Lindau phantsi kweemeko ezithile
33 Nexviazyme i-avalglucosidase alfa-ngpt 8/6/2021 Ukunyanga isifo sePompe emva kwexesha
Upapasho ndaba zekhampani
32 Saphnelo anifrolumab-fnia 7/30/2021 Ukunyanga i-systemic lupus erythematousus ephakathi ukuya kobunzima kunye nonyango oluqhelekileyo
31 Bylvay odevixibat 7/20/2021 Ukunyanga i-pruritus
30 Rezurock belumosudil 7/16/2021 Ukunyanga isifo esinganyangekiyo sokuxhunyelelwa-kunye-nomkhosi emva kokusilela ubuncinci kwimigca emibini yangaphambili yonyango lwenkqubo
29 fexidazole fexidazole 7/16/2021 Ukunyanga itrypanosomiasis yabantu baseAfrika ebangelwa yi-parasite Trypanosoma brucei gambinse
28 Kerendia finerenone 7/9/2021 Ukunciphisa umngcipheko weentso kunye neengxaki zentliziyo kwisifo esingapheliyo sesifo esinxulumene nesifo seswekile se-2
27 Rylaze i-asparaginase erwinia chrysanthemi (i-recombinant) -rywn 6/30/2021 Ukunyanga i-acute lymphoblastic leukemia kunye ne-lymphoblastic lymphoma kwizigulana ezingadibaniyo ne-E. coli-derived asparaginase iimveliso, njengenxalenye yerejimeni yechemotherapy
Upapasho ndaba zekhampani
26 Aduhelm aducanumab-avwa 6/7/2021 Ukunyanga isifo sika-Alzheimer
Upapasho ndaba zekhampani
25 Brexafemme ibrexafungerp 6/1/2021 Ukunyanga i-vulvovaginal candidiasis
24 Lybalvi i-olanzapine kunye ne-samidorphan 5/28/2021 Ukunyanga i-schizophrenia kunye nemiba ethile ye-bipolar I disorder
23 Truseltiq infigratinib 5/28/2021 Ukunyanga i-cholangiocarcinoma enesifo esihlangabezana neekhrayitheriya ezithile
22 Lumakras sotorasib 5/28/2021 Ukunyanga iintlobo zomhlaza wemiphunga weseli engeyiyo encinci
Upapasho ndaba zekhampani
21 I-Pylarify ipiflufolastat F18 5/26/2021 Ukuchonga izilonda ze-prostate-specific membrane antigen-positive kumhlaza we-prostate
20 Rybrevant amivantamab-vmjw 5/21/2021 Ukunyanga iseti yomhlaza wemiphunga yeseli engeyiyo encinci
Upapasho ndaba zekhampani
19 Empaveli pegcetacoplan 5/14/2021 Ukunyanga i-paroxysmal nocturnal hemoglobinuria
18 Zynlonta loncastuximab tesirine-lpyl 4/23/2021 Ukunyanga iintlobo ezithile ze-lymphoma ephindaphindayo okanye i-refractory enkulu ye-B-cell lymphoma
17 Jemperli dostarlimab-gxly 4/22/2021 Ukunyanga umhlaza we-endometrial
Upapasho ndaba zekhampani
16 Ezilandelayo drospirenone kunye ne estetrol 4/15/2021 Ukuthintela ukukhulelwa
15 Qelbree viloxazine 4/2/2021 Ukunyanga ukunqongophala kwengxaki yokungasebenzi kakuhle
14 Zegalogue i-dasiglucagon 3/22/2021 Ukunyanga i-hypoglycemia enzima
13 Iponvory ponesimod 3/18/2021 Ukunyanga iindlela ezibuyela umva zemultiple sclerosis
12 Fotivda tivozanib 3/10/2021 Ukunyanga i-renal cell carcinoma
11 Azstarys serdexmethylphenidate kunye 3/2/2021 Ukunyanga ukunqongophala kwengxaki yokungasebenzi kakuhle
dexmethylphenidate
10 Pepaxto melphalan flufenamide 2/26/2021 Ukunyanga i-myeloma ephindaphindiweyo okanye echasayo
9 Nulibry fosdenopteri 2/26/2021 Ukunciphisa umngcipheko wokusweleka kwi-molybdenum cofactor yokusilela udidi A
Upapasho ndaba zekhampani
8 IiAmonds 45 casimersen 2/25/2021 Ukunyanga iDuchenne muscular dystrophy
Upapasho ndaba zekhampani
7 Cosela trilacicilib 2/12/2021 Ukunciphisa ichemotherapy-induced myelosuppression kumhlaza wemiphunga omncinci weseli
Upapasho ndaba zekhampani
6 Evkeeza evinacumab-dgnb 2/11/2021 Ukunyanga i-homozygous yosapho lwe-hypercholesterolemia
5 Ukoniq umbralisib 2/5/2021 Ukunyanga i-lymphoma ye-marginal zone kunye ne-follicular lymphoma
4 Tepmetko itepotinib 2/3/2021 Ukunyanga umhlaza wemiphunga weseli ongemncinci
3 Lupkynis iVoclosporin 1/22/2021 Ukunyanga i-lupus nephritis
Iimvavanyo zeziyobisi Isifinyezo
2 Cabenuva I-cabotegravir kunye ne-rilpivirine (zipakishwe kunye) 1/21/2021 Ukunyanga i-HIV
Upapasho ndaba zekhampani
Iimvavanyo zeziyobisi Isifinyezo
1 Verquvo vericiguat 1/19/2021 Ukunciphisa umngcipheko wokufa kwentliziyo kunye nokulaliswa esibhedlele ngenxa yokungaphumeleli kwentliziyo
Iimvavanyo zeziyobisi Isifinyezo

 

Uluhlu "losetyenziso oluvunyiweyo lwe-FDA" kule webhusayithi yenzelwe iinjongo zokubonisa kuphela.Ukubona iimeko zokusetyenziswa ezivunyiweyo ze-FDA [umzekelo, izalathisi, (s), abantu), irejimeni yedosi (s)] nganye kwezi mveliso, jonga olona lwazi lwamva nje oluvunyiweyo lwe-FDA.
Caphula kwiwebhusayithi ye-FDA:https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2021


Ixesha lokuposa: Sep-27-2021